Evidence reviewed: 8 November 2026. Parkinson’s disease is a progressive neurological condition most readily recognized by slowness of movement (bradykinesia), often accompanied by resting tremor, stiffness or other motor changes. It can also cause constipation, sleep disturbance, reduced sense of smell, mood changes, fatigue and cognitive symptoms. Modern care focuses on improving function and quality of life with appropriate medicines, physical activity and multidisciplinary support. Parkinson’s disease is not always dominated by tremor, and progression is highly individual [1–3].
What happens in Parkinson’s disease?
Parkinson’s involves degeneration of dopamine-producing neurons in the substantia nigra and changes in the brain circuits that regulate movement. Abnormal accumulation of alpha-synuclein is a characteristic biological feature in many forms, but individual causes and patterns vary. The resulting reduction in dopamine signaling impairs the ability to initiate and smoothly control movement. Other neurotransmitter pathways also contribute to nonmotor symptoms [2,3].
Most cases are sporadic, although some are associated with inherited genetic variants. Older age is an important risk factor, but the disease can occur in younger adults. Certain environmental exposures and protective associations are being studied; no single lifestyle factor has been shown to explain every case or provide a guaranteed prevention method.
Four important motor signs
1. Bradykinesia: the central clinical feature
Bradykinesia means slowness of movement, usually with reduced movement size or speed during repeated actions. A person may take longer to button clothes, write smaller letters (micrographia), blink less, or have reduced arm swing while walking. Bradykinesia is necessary for the clinical diagnosis of parkinsonism; tremor alone is insufficient [2].
2. Resting tremor
A rhythmic tremor may affect a hand or foot when the limb is relaxed and lessen with purposeful movement. It may start asymmetrically. Not everyone with Parkinson’s develops a prominent tremor; and an action or essential tremor can have a different cause.
3. Rigidity
Muscle stiffness or resistance to passive movement can cause uncomfortable shoulders, slow turning or difficulty with ordinary tasks. A clinician may detect rigidity during examination; pain alone does not establish Parkinson’s disease.
4. Gait and postural changes
Short steps, stooping, reduced arm swing, turning difficulty and freezing of gait can occur. Balance and falls may become more problematic as disease progresses. Repeated falls very early in the disease, especially with gaze abnormalities or other atypical findings, should prompt assessment for alternative parkinsonian syndromes [2].
Nonmotor symptoms: an essential part of Parkinson’s care
- Reduced sense of smell, sometimes predating movement symptoms.
- Constipation, urinary urgency or low blood pressure on standing.
- REM sleep behavior disorder, involving dream enactment during sleep.
- Depression, anxiety, apathy or fatigue.
- Pain, sleep problems, swallowing changes or drooling.
- In some people, cognitive changes, hallucinations or dementia, particularly later in the disease.
These symptoms are not unique to Parkinson’s, and their presence alone does not make the diagnosis. They should nonetheless be asked about and treated appropriately, because nonmotor problems can have a major impact on daily life [1].
How is Parkinson’s disease diagnosed?
Diagnosis is primarily clinical, based on a neurological history and examination. NICE recommends referring a person with suspected Parkinson’s quickly and untreated to a specialist with expertise in the differential diagnosis of movement disorders. Clinical criteria require bradykinesia plus at least one other characteristic motor feature such as rigidity or resting tremor, while assessing warning signs and alternative causes [1,2].
There is no single routine blood test or brain scan that establishes Parkinson’s disease in every patient. MRI may help investigate an atypical presentation or alternative diagnosis, but is not used as a routine test to diagnose typical Parkinson’s. Dopamine-transporter SPECT imaging may help in selected uncertain cases, for example where essential tremor must be distinguished from degenerative parkinsonism; it does not by itself establish the exact disease subtype [1].
What conditions can resemble Parkinson’s?
Drug-induced parkinsonism may occur with dopamine-blocking medicines such as certain antipsychotics or metoclopramide. Essential tremor, vascular parkinsonism and atypical degenerative syndromes such as progressive supranuclear palsy, multiple system atrophy or dementia with Lewy bodies can share features. Review the patient’s medications and timing of symptoms before concluding that the cause is idiopathic Parkinson’s disease [1,2].
How does Parkinson’s progress?
Parkinson’s generally changes over years, but the pace and specific symptoms differ widely. Some people remain independent for a long time with treatment; others develop motor fluctuations, postural instability or cognitive difficulties. The Hoehn and Yahr staging system summarizes motor disability, but a stage does not predict the exact future course or encompass nonmotor burden.
| Broad disease phase | Possible challenges | Care priorities |
|---|---|---|
| Early symptomatic disease | Asymmetric tremor or slowness, stiffness, reduced dexterity. | Confirm diagnosis, discuss treatment goals, support exercise and function. |
| Established disease | Medication benefit may become less predictable; walking, sleep and nonmotor symptoms may need closer attention. | Adjust medicines with specialist help, prevent falls, add therapy services. |
| More advanced disease | Severe fluctuations, freezing, falls, swallowing problems or cognition-related difficulties in some people. | Individualized advanced treatment, rehabilitation, care planning and support. |
Not every person follows the same pattern or experiences every complication. Changes in symptoms should also prompt evaluation for other issues, such as infection, dehydration, constipation or medication effects.
Levodopa: the most effective symptomatic motor therapy
Levodopa is converted to dopamine in the brain, usually given with a peripheral decarboxylase inhibitor such as carbidopa or benserazide to reduce peripheral adverse effects. It is the most effective medicine for many motor symptoms. NICE recommends offering levodopa when motor symptoms affect quality of life. For milder early symptoms not affecting quality of life, a shared decision may consider levodopa, a dopamine agonist or an MAO-B inhibitor, accounting for differing effectiveness and risks [1].
Do not delay necessary levodopa solely out of fear that it is inherently toxic to the brain. Over time, fluctuations in response and involuntary movements (dyskinesias) can develop, reflecting disease evolution, treatment exposure and individual factors. These complications call for a personalized neurologist-led plan, not abrupt withdrawal of treatment.
Other Parkinson’s medicines and important safety issues
| Class | Use and cautions |
|---|---|
| Dopamine agonists (e.g., pramipexole, ropinirole, rotigotine) | Stimulate dopamine receptors. Can cause sleepiness, edema, hallucinations and impulse-control disorders, including compulsive gambling, shopping or sexual behaviors. |
| MAO-B inhibitors (e.g., rasagiline, selegiline, safinamide) | Offer symptomatic benefit or adjunctive effects; monitor interactions and individual contraindications. Not proven to halt neurodegeneration. |
| COMT inhibitors (e.g., entacapone, opicapone) | May prolong levodopa effects when wearing-off occurs; can increase dopaminergic side effects. |
| Amantadine | May help selected dyskinesias; potential hallucinations, edema and renal-dose considerations. |
| Anticholinergics | Limited selected use, mainly for troublesome tremor in younger patients; cognitive, urinary and other adverse effects restrict use, especially in older adults. |
Impulse-control symptoms deserve routine screening because affected people may conceal them. NICE recommends discussing these risks before starting dopamine agonists and reviewing them during follow-up [1]. Family members should know whom to contact if major behavioral changes emerge.
Never stop Parkinson’s medicines abruptly
Sudden withdrawal or major reduction of dopaminergic treatment can lead to severe immobility and a potentially life-threatening syndrome resembling neuroleptic malignant syndrome. Medicines should be administered on time, including during hospital admission; prescribing errors and missed doses can cause harm. Discuss swallowing difficulties or surgical fasting with the clinical team before doses are missed. Some antiemetics and antipsychotics can worsen parkinsonism through dopamine blockade [1].
Managing motor fluctuations and advanced disease
People may develop wearing-off—symptoms returning before the next levodopa dose—ON/OFF fluctuations, involuntary dyskinesia or gait freezing. A neurologist may adjust timing, formulation, adjunctive medicines or other therapies. Selected people with disabling symptoms despite optimized medicines may be evaluated for deep brain stimulation or other device-aided treatments [1].
Deep brain stimulation can improve particular movement symptoms and reduce fluctuations in carefully chosen patients, but is not a cure and does not reliably reverse speech, cognitive or all balance problems. Careful selection considers cognition, mood, overall medical health and expected benefit.
Exercise, physiotherapy and day-to-day support
NICE recommends Parkinson-specific physiotherapy for people with balance or motor problems and occupational therapy for difficulties with daily activities. A personalized exercise programme may involve walking, resistance training, balance work and flexibility activities within safe limits. Speech and language therapy can help communication and swallowing problems, which should be assessed when present [1].
Falls prevention, footwear, home modifications, sufficient nutrition and management of orthostatic hypotension, constipation, sleep and mood can improve functioning. Encourage people to remain socially involved and to discuss driving and work safety as symptoms evolve.
Frequently asked questions
Does every Parkinson’s patient have tremor?
No. Bradykinesia is central to the clinical syndrome, and some people have minimal or no tremor [2].
Is levodopa a last-resort medicine?
No. NICE recommends levodopa when motor symptoms affect quality of life [1].
Can Parkinson’s medicines cause behavioral changes?
Yes. Dopamine agonists can cause impulse-control problems, and other dopaminergic medicines can contribute to hallucinations or excessive sleepiness [1].
Can exercise cure Parkinson’s?
No. Physical activity helps function, fitness and quality of life, but no exercise programme has been established as a cure.
What if symptoms suddenly worsen?
Seek medical assessment for infection, missed medication, dehydration or another acute problem rather than automatically assuming predictable disease progression.
Key takeaways
Recognize bradykinesia and associated motor and nonmotor signs, seek specialist diagnosis, and treat symptoms to improve quality of life. Levodopa is highly effective, but medicine safety and regular rehabilitation matter throughout the course.
References
- National Institute for Health and Care Excellence. Parkinson’s disease in adults: diagnosis and management (NG71). London: NICE; accessed 8 Nov 2026.
- Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–1601. doi:10.1002/mds.26424.
- National Institute on Aging. Parkinson’s disease: symptoms, diagnosis and treatment. NIH; accessed 8 Nov 2026.
Medical disclaimer: General educational information, not a personalized diagnosis or prescription. Parkinson’s medicines require clinician-directed timing and adjustment. Do not abruptly discontinue dopaminergic treatment; seek urgent help for sudden severe deterioration or swallowing and breathing problems.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.